Growth Stock Wire Investment Newsletter

 
Growth Stock Wire Investment Newsletter About Growth Stock Wire Frequently Asked Questions Growth Stock Wire Archives Contact Us Privacy Policy
Print Edition | Sponsored Link:
What the Gov't Won't Tell You About Health Care Reform
By Rob Fannon
July 10, 2009

On Wednesday, Vice President Biden bragged that the government had extracted a pledge from the nation's hospital industry to cut $155 billion in costs over the next decade.

That might sound like terrible news for hospital investors... But as I'll show you, the hospitals – and their shareholders – are set to come out way ahead on President Obama's health care reform.

Obama's concept of health care reform is almost entirely focused on extending coverage to the 50 million uninsured Americans. As the number of uninsured shrinks, the amount of health care spending goes up. All sorts of health care providers – doctors, drugmakers, hospitals – win.

The only problem is, who's going to cover the estimated $1 trillion cost over the next 10 years? Back in May, Obama hosted a Kumbaya campfire session at the White House with the major health care stakeholders. The collective lot pledged $2 trillion in savings over the next decade. Now, one by one, the various players in the medical industry are unveiling their specific cost-saving plans.

First up were the drugmakers. Big Pharma recently pledged $80 billion over 10 years to extend drug discounts to Medicare patients who fall into a coverage gap. But as my colleague George Huang pointed out, the extended coverage helps patients stay on their brand-name drugs instead of switching to generics... or stopping their prescription all together. So the "cost-cutting" deal is actually a big positive for Pfizer, Merck, and the other big players.

Just like Big Pharma, hospitals are set to cash in on the pending health care reform. Here's why the hospitals' $155 billion, 10-year "concession" actually works to industry's benefit:

First, hospitals have joined drugmakers in building goodwill with influential allies as the final health care reform bill hits the House and Senate floors. It's a classic "can't beat 'em, join 'em" move.

Second, the final $155 billion figure is down from the $220 billion the White House proposed. Score one for the hospital lobbyists.

Third, the Medicare and Medicaid hospital reimbursement cuts will be phased in over time, with larger cuts back-loaded as uninsured patients gain coverage to become "paying customers."

Finally, and perhaps most important, if a government-sponsored insurance plan emerges from the reform to compete with private plans, hospitals will be reimbursed at rates higher than current Medicare and Medicaid payments.

Right now, for example, the uninsured population adds $120 billion to our annual health care costs. Hospitals directly absorb about $40 billion of that. So as the uninsured gain medical coverage, hospital earnings inevitably improve. And as investors get excited about the idea, these stocks will soar.

 
Related Articles
Why It's Finally Time to Buy Big Pharma
Biotech's Latest Hot-Money Trend
 
The five largest publicly traded hospital chains are Universal Health Services (UHS), Community Health Systems (CYH), Lifepoint Hospitals (LPNT), Tenet Healthcare (THC), and Health Management Associates (HMA). Now, before you jump in with both feet, you should know all these guys are highly leveraged. The hospital business is enormously capital-intensive. And the margins are notoriously unreliable.

But with all the news about Obama's plans, each of these stocks has jumped. And over the next few months, as health care reform continues to march from campaign pledge to reality, you can expect these stocks to move up at least another 25% from here.

Good investing,

Rob Fannon

The only gold investment Wall Street can't ruin
Why one investor won't touch gold miners or ETFs...

This company is going to dominate nuclear power plant construction
The "evolutionary power reactor" is on its way...

Switzerland says "NO," refuses U.S. requests
Seizes UBS client information.


Uptrend in cheap continues... discount department chain Ross Stores hits a 52-week high, TJX Companies at nine-month high.
Natty misery: Major natural gas trust San Juan Basin Royalty hits new 52-week low.
Beaten-up casino stocks Wynn, Boyd, Las Vegas Sands, MGM jump on report of higher gambling traffic.
Earnings today... Infosys, Audiovox.
Last Change 52-Wk
S&P 500 886.08 +0.74% -28.81%
Oil (USO) 32.36 -0.64% -70.49%
Gold (GLD) 89.90 +0.71% -1.75%
Silver (SLV) 12.74 +0.38% -29.04%
U.S. Dollar 79.83 -1.00% +9.93%
Euro
1.40
+1.23%
-10.76%
VIX 29.54 -5.62% +17.08%
HUI 322.74 +3.12% -22.98%
10-Year Yield 3.40% 0.11 -0.39

Advertisement

Company Sym Industry

Transcend Services

TRCR

medical dictation

Orchids Paper

TIS

paper products

Books-A-Million

BAMM

book stores

Stanley Furniture

STLY

home furnishings

Ross Stores

ROST

clothing retail

Helix Wind

HLXW

wind turbines

Vortex Resources

VXRC

oil & gas drilling

ICU Medical

ICUI

medical devices

Schweitzer-Mauduit

SWM

paper products

Company Sym Industry

Omega Navigation

ONAV

shipping

CVB Financial

CVBF

bank

Green Bankshares

GRNB

bank

Medidata Solutions

MDSO

health care IT

CardioNet

BEAT

medical devices

Sterling Bancorp

STL

bank

Cardima

CADM

medical devices

Standard Register

SR

office supplies

Cephalon

CEPH

pharma

Citizens Republic

CRBC

bank

APP Pharma

ABII

biotech

How to 'Juice' Your Conservative Portfolio
July 9, 2009

Cap and Trade Part Two: How We'll Profit

July 8, 2009

Your Best Shot to Buy Cheap Gold This Year

July 7, 2009

The Perfect Investment

July 6, 2009

Weekend Edition: Why You Can't Make Money Investing in the Oil Majors

July 04, 2009

Home | About GSW | FAQ | GSW Archive | Privacy Policy | Contact Us

Customer Service: 1-888-261-2693 – Copyright 2010 Stansberry & Associates Investment Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This e-letter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry & Associates Investment Research, LLC. 1217 Saint Paul Street, Baltimore MD 21202